PART I Overview Theravance Biopharma, Inc. (we, our, Theravance Biopharma or the Company) is a biopharmaceutical company primarily focused on the development and commercialization of medicines. Our focus is to deliver medicines that make a difference in peoples lives. In pursuit of our purpose, we leverage decades of expertise, which has led to the development of the United States (US) Food and Drug Administration (the FDA) approved YUPELRI (revefenacin) inhalation solution indicated for the mai...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-23 | 2025-12-31 | 0001104659-26-033077 | EDGAR | 69K words |
| 2025-03-07 | 2024-12-31 | 0001558370-25-002447 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0001558370-24-002267 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001558370-23-002595 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002373 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001558370-21-002006 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001558370-20-001644 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001558370-19-001346 | EDGAR | — |
| 2018-02-28 | 2017-12-31 | 0001047469-18-001160 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001047469-17-001086 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001104659-26-093773 | EDGAR | — |
| 2025-11-12 | 2025-09-30 | 0001104659-25-110382 | EDGAR | 46K words |
| 2025-08-13 | 2025-06-30 | 0001558370-25-011408 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001558370-25-007398 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015602 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011636 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008201 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018612 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001558370-23-014070 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001558370-23-008951 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001558370-22-017048 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001558370-22-012666 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001104659-26-093066 | EDGAR | — |
| 2026-03-30 | 0001104659-26-036870 | EDGAR | 1K words |
| 2026-03-19 | 0001104659-26-031795 | EDGAR | — |
| 2026-03-03 | 0001104659-26-022572 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002726 | EDGAR | — |
| 2025-12-08 | 0001104659-25-119032 | EDGAR | — |
| 2025-11-10 | 0001104659-25-109146 | EDGAR | — |
| 2025-08-25 | 0001104659-25-082048 | EDGAR | — |
| 2025-08-20 | 0001104659-25-080470 | EDGAR | — |
| 2025-08-12 | 0001104659-25-076837 | EDGAR | — |
241 total filings indexed. 209 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001583107 |
| Ticker | TBPH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | CA |
| Website | https://www.theravance.com |
| Listed | 2014-05-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TBPH (~200 tokens, structured JSON with cryptographic provenance)